PaxMedica, Inc. (PXMD)
OTCMKTS · Delayed Price · Currency is USD
0.0007
+0.0002 (40.00%)
Jun 17, 2026, 9:30 AM EST
PaxMedica Market Cap
PaxMedica has a market cap or net worth of $63.14 thousand as of June 17, 2026. Its market cap has decreased by -96.31% in one year.
Market Cap
63.14K
Enterprise Value
-381.71K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 26, 2022, PaxMedica's market cap has decreased from 49.18M to 63.14K, a decrease of -99.87%. That is a compound annual growth rate of -82.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 63.14K | 400.06% |
| Dec 31, 2025 | 12.63K | -98.19% |
| Dec 31, 2024 | 697.96K | -79.65% |
| Dec 29, 2023 | 3.43M | -85.66% |
| Dec 30, 2022 | 23.91M | -51.38% |
| Aug 26, 2022 | 49.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sigyn Therapeutics | 99.18K |
| Affymax | 96.84K |
| Nascent Biotech | 69.14K |
| Scorpius Holdings | 67.26K |
| Vincerx Pharma | 66.48K |
| U.S. Stem Cell | 66.15K |
| Panbela Therapeutics | 53.89K |
| Mera Pharmaceuticals | 53.67K |